New data for investigational nipocalimab in Sjögren's Disease (SjD) and new research on the impact of TREMFYA® (guselkumab) in psoriatic arthritis (PsA) will be highlighted across three oral sessions ...

We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.